Tony Michael Argenbright

Array ( [id] => 5851751 [patent_doc_number] => 20060234942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Use of at least one $g(a)62 casein peptide with angiotensin i converting enzyme inhibiting activity for preparing medicines, food products and food complements' [patent_app_type] => utility [patent_app_number] => 10/519164 [patent_app_country] => US [patent_app_date] => 2003-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4618 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234942.pdf [firstpage_image] =>[orig_patent_app_number] => 10519164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6957960 [patent_doc_number] => 20050214330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Process for producing sustained-release composition' [patent_app_type] => utility [patent_app_number] => 10/518914 [patent_app_country] => US [patent_app_date] => 2003-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14782 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214330.pdf [firstpage_image] =>[orig_patent_app_number] => 10518914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7038813 [patent_doc_number] => 20050158247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Nasal peptide pharmaceutical formulation' [patent_app_type] => utility [patent_app_number] => 10/516613 [patent_app_country] => US [patent_app_date] => 2003-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7637 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158247.pdf [firstpage_image] =>[orig_patent_app_number] => 10516613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7400866 [patent_doc_number] => 20040018984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Methods for preventing adhesion formation using protease inhibitors' [patent_app_type] => new [patent_app_number] => 10/602035 [patent_app_country] => US [patent_app_date] => 2003-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9344 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20040018984.pdf [firstpage_image] =>[orig_patent_app_number] => 10602035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7256028 [patent_doc_number] => 20040259802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Anti-chrondrosarcoma compounds' [patent_app_type] => new [patent_app_number] => 10/601059 [patent_app_country] => US [patent_app_date] => 2003-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 19905 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259802.pdf [firstpage_image] =>[orig_patent_app_number] => 10601059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5194376 [patent_doc_number] => 20070082860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Hla-a24-restricted cancer antigen peptides' [patent_app_type] => utility [patent_app_number] => 10/517600 [patent_app_country] => US [patent_app_date] => 2003-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 20923 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082860.pdf [firstpage_image] =>[orig_patent_app_number] => 10517600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7462911 [patent_doc_number] => 20040053206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Methods for preserving organs and tissues' [patent_app_type] => new [patent_app_number] => 10/456981 [patent_app_country] => US [patent_app_date] => 2003-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11513 [patent_no_of_claims] => 97 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053206.pdf [firstpage_image] =>[orig_patent_app_number] => 10456981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7535224 [patent_doc_number] => 08048850 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-01 [patent_title] => 'Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use' [patent_app_type] => utility [patent_app_number] => 10/457078 [patent_app_country] => US [patent_app_date] => 2003-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6922 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/048/08048850.pdf [firstpage_image] =>[orig_patent_app_number] => 10457078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020097 [patent_doc_number] => 20050222116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Porphyrin oxygen infusion preparation for increasing oxygen concentration in tumor tissue' [patent_app_type] => utility [patent_app_number] => 10/516588 [patent_app_country] => US [patent_app_date] => 2003-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6138 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222116.pdf [firstpage_image] =>[orig_patent_app_number] => 10516588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 544533 [patent_doc_number] => 07163917 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-16 [patent_title] => 'Synthesis method of alanylglutamine' [patent_app_type] => utility [patent_app_number] => 10/518940 [patent_app_country] => US [patent_app_date] => 2003-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4512 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/163/07163917.pdf [firstpage_image] =>[orig_patent_app_number] => 10518940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7264955 [patent_doc_number] => 20040242491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Composition containing dipeptide of histidine and alanine for reducing uric acid and method for reducing uric acid using the dipeptide' [patent_app_type] => new [patent_app_number] => 10/449053 [patent_app_country] => US [patent_app_date] => 2003-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2682 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242491.pdf [firstpage_image] =>[orig_patent_app_number] => 10449053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6967079 [patent_doc_number] => 20050233976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Therapeutic methods' [patent_app_type] => utility [patent_app_number] => 10/515981 [patent_app_country] => US [patent_app_date] => 2003-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3751 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20050233976.pdf [firstpage_image] =>[orig_patent_app_number] => 10515981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7303155 [patent_doc_number] => 20040115132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Protein cages for the delivery of medical imaging and therapeutic agents' [patent_app_type] => new [patent_app_number] => 10/441962 [patent_app_country] => US [patent_app_date] => 2003-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 22504 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115132.pdf [firstpage_image] =>[orig_patent_app_number] => 10441962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7232977 [patent_doc_number] => 20050256054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Drug therapy for celiac sprue' [patent_app_type] => utility [patent_app_number] => 10/514005 [patent_app_country] => US [patent_app_date] => 2003-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 118927 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256054.pdf [firstpage_image] =>[orig_patent_app_number] => 10514005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5801325 [patent_doc_number] => 20060035838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Drug therapy for celiac sprue' [patent_app_type] => utility [patent_app_number] => 10/514177 [patent_app_country] => US [patent_app_date] => 2003-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11556 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035838.pdf [firstpage_image] =>[orig_patent_app_number] => 10514177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840593 [patent_doc_number] => 20080281079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Bioactivation Of Particles' [patent_app_type] => utility [patent_app_number] => 10/513567 [patent_app_country] => US [patent_app_date] => 2003-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9140 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20080281079.pdf [firstpage_image] =>[orig_patent_app_number] => 10513567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7675218 [patent_doc_number] => 20040126900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'High affinity peptide- containing nanoparticles' [patent_app_type] => new [patent_app_number] => 10/257455 [patent_app_country] => US [patent_app_date] => 2003-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17307 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20040126900.pdf [firstpage_image] =>[orig_patent_app_number] => 10257455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6702154 [patent_doc_number] => 20030225034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Surfactant prevention of vaginitis and lung complications from cancer chemotherapy' [patent_app_type] => new [patent_app_number] => 10/428598 [patent_app_country] => US [patent_app_date] => 2003-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12908 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20030225034.pdf [firstpage_image] =>[orig_patent_app_number] => 10428598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 680063 [patent_doc_number] => 07084134 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-01 [patent_title] => 'Thrombin inhibitors' [patent_app_type] => utility [patent_app_number] => 10/427435 [patent_app_country] => US [patent_app_date] => 2003-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8417 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/084/07084134.pdf [firstpage_image] =>[orig_patent_app_number] => 10427435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7377590 [patent_doc_number] => 20040220080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Pharmaceutical composition as solid dosage form and method for manufacturing thereof' [patent_app_type] => new [patent_app_number] => 10/425993 [patent_app_country] => US [patent_app_date] => 2003-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3015 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220080.pdf [firstpage_image] =>[orig_patent_app_number] => 10425993 [rel_patent_id] =>[rel_patent_doc_number] =>)